Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Swiss Federal Institute of Technology Zurich (ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, biology, agricultural science, agroecosystem science, biomedical engineering, and food science among others. It offers research in various disciplines such as world food system, health, risk research, information processing, cities of the future, climate change, energy, new materials and industrial processes, through several competence centres.

Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detai

  
Source:
Document ID
GDPH230392D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Swiss Federal Institute of Technology Zurich, Medical Devices Deals, 2010 to YTD 201691
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Swiss Federal Institute of Technology Zurich, Pharmaceuticals &Healthcare, Deal Details1213
  Partnerships121
    Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich121
    CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping131
    Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich142
    IBM Enters Into Research Agreement With ETH Zurich And CloudBroker161
    McGill University Forms Joint Venture With University Of Zurich And Swiss Federal Institute Of Technology172
    AB SCIEX Partners With ETH Zurich Institute of Molecular Systems Biology192
  Licensing Agreements211
    Biognosys Enters into Licensing Agreement with ETH Zurich Foundation211
    Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology221
    Swiss Federal Institute Of Technology Enters Into Licensing Agreement With Cell Culture Technologies231
    CovalX Enters Into Licensing Agreement With ETH Zurich For Cross Linking Molecule Patents241
Swiss Federal Institute of Technology Zurich - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Swiss-Federal-Institute-of-Technology-Zurich-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20614>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Swiss Federal Institute of Technology Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Swiss-Federal-Institute-of-Technology-Zurich-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20614>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research